Points of view in assessment and treatment of prostatic hypertrophy
Aberle, B.
Wiener Medizinische Wochenschrift 121(37): 638-642
1971
ISSN/ISBN: 0043-5341 PMID: 4106789 Document Number: 32449
Document emailed within 1 workday
Related Documents
Castro, J.E.; Griffiths, H.L. 1972: The assessment of patients with benign prostatic hypertrophy Journal of the Royal College of Surgeons of Edinburgh 17(3): 190-194Günther, K.H.; Fiehring, H. 1977: New view points on the treatment of heart insufficiency Zeitschrift für Arztliche Fortbildung 71(8): 376-378
Romics, I. 2003: Treatment of benign prostatic hypertrophy Orvosi Hetilap 144(45): 2229-2230
Nilsson, S. 1995: TUV-p is a logical name for the new treatment of prostatic hypertrophy Lakartidningen 92(47): 4405
Martini, E.; Vaggi, L.; Rucci, A.; Di Clemente, L. 1994: Non-surgical treatment of benign prostatic hypertrophy Journal de Chirurgie 131(10): 445-449
Fateri, F.; Caviezel, A.; Saaidia, A.; Iselin, C. 2005: Treatment of symptomatic prostatic hypertrophy with the KTP-80 laser Revue Medicale Suisse 1(44): 2867-2869
Schulman, C.C. 1993: Surgical treatment of benign prostatic hypertrophy European Urology 23(2): 261
Kato, T.; Okada, K. 1970: Treatment of prostatic hypertrophy with 19-norhydroxyprogesterone caproate Hinyokika Kiyo. Acta Urologica Japonica 16(9): 489-500
Dusková, M.; Helclová, H. 1987: The problem of timing surgical treatment for hypospadias from the surgeon's and psychologist's points of view Acta Chirurgiae Plasticae 29(4): 220-228
Hruby, K. 1974: Treatment of senile degenerative maculopathies by etaretin. Prospects of success and economical points of view Klinische Monatsblatter für Augenheilkunde 165(1): 68-70
Kazama, T.; Mizuno, I.; Takamine, T.; Umeda, K.; Terada, T.; Ishikawa, S.; Fuse, H.; Katayama, T. 1990: Evaluation of anti-androgen therapy for benign prostatic hypertrophy by using transrectal prostatic ultrasonography Hinyokika Kiyo. Acta Urologica Japonica 36(12): 1423-1427
Nakajima, H.; Yui, Y.; Akimoto, M. 1985: Clinical evaluation of surgical treatment for benign prostatic hypertrophy Hinyokika Kiyo. Acta Urologica Japonica 31(1): 101-106
Larosa, M.; Ferretti, S.; Salsi, P.; Simonazzi, M. 1994: Use of terazosin and alfuzosin in the treatment of benign prostatic hypertrophy (BPH): our experience Acta Bio-Medica de l'Ateneo Parmense 65(1-2): 23-28
Virgili, G.; Mearini, E.; Sbarberi, L.; Camilli, P.; Costantini, E. 1986: Therapeutic efficacy of mepartricin in the medical treatment of prostatic hypertrophy Minerva Medica 77(20): 861-866
Giurioli, A.; Rosi, P.; Parziani, S.; Cesaroni, M.; Ghamari, M.R. 1988: Treatment of benign prostatic hypertrophy using mepartricin at high dosage Minerva Urologica e Nefrologica 40(2 Suppl): 38-39
Bouffioux, C. 1995: How I treat.... Benign prostatic hypertrophy. Part 1: restatement and nonmedical treatment Revue Medicale de Liege 50(2): 53-54
Górecki, R.; Krzeski, T.; Wasik, J.; Borówka, A. 1992: Evaluation of the effectiveness of prazosin in conservative treatment of benign prostatic hypertrophy Polski Tygodnik Lekarski 47(24-26): 549-551
Theodorou, C.; Moutzouris, G.; Floratos, D.; Plastiras, D.; Katsifotis, C.; Mertziotis, N. 1998: Incontinence after surgery for benign prostatic hypertrophy: the case for complex approach and treatment European Urology 33(4): 370-375
Matsuura, T.; Wakabayashi, A.; Kaneko, S.; Kurita, T. 1986: Conservative treatment of benign prostatic hypertrophy: reevaluation of the effect of eviprostat by subjective symptoms and uroflowmetry Hinyokika Kiyo. Acta Urologica Japonica 32(6): 903-906
Akata, T.; Yoshimura, H.; Matsumae, Y.; Shiokawa, H.; Fukumoto, T.; Kandabashi, T.; Yamaji, T.; Takahashi, S. 2004: Changes in serum Na+ and blood hemoglobin levels during three types of transurethral procedures for the treatment of benign prostatic hypertrophy Masui. Japanese Journal of Anesthesiology 53(6): 638-644